Homeopathy 2016; 105(01): 42-47
DOI: 10.1016/j.homp.2015.09.004
Original Paper
Copyright © The Faculty of Homeopathy 2015

Homeopathic Rhus toxicodendron has dual effects on the inflammatory response in the mouse preosteoblastic cell line MC3T3-e1

Kyung Jin Lee
1   Department of Convergence Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, South Korea
,
Myeong Gu Yeo
2   Department of Integrative Medical Sciences, Nambu University, Gwangju 506-706, South Korea
› Author Affiliations

Subject Editor:
Further Information

Publication History

Received13 October 2014
revised29 July 2015

accepted21 September 2015

Publication Date:
23 December 2017 (online)

Background: Homeopathic remedy Rhus toxicodendron (Rhus tox) is used for several symptoms including skin irritations, rheumatic pains, mucous membrane afflictions, and typhoid type fever. Previously, we reported that Rhus tox treatment increased the cyclooxygenase-2 (COX-2) mRNA expression in primary cultured mouse chondrocytes.

Methods: A preosteoblastic mouse cell line, MC3T3-e1, was treated with different homeopathic dilutions of Rhus tox and the COX-2 mRNA and protein expression was examined using reverse transcriptase-polymerase chain reaction (RT-PCR) and immunoblotting. Additionally, nitric oxide (NO) generation was examined in LPS-induced MC3T3-e1 cells using a Griess reaction assay.

Results: Stimulation with different concentrations of Rhus tox increased the expression of Cox2 mRNA, with 30X Rhus tox showing the most prominent increase in mRNA expression. In addition, treatment with 30X Rhus tox significantly increased prostaglandin E2 (PGE2) release compared with other homeopathic dilutions. However, the COX-2 protein expression level differed slightly from its mRNA expression, because the 30C Rhus tox treatment increased COX-2 protein to a greater extent compared with other dilutions. NO generation was dramatically decreased in MC3T3-e1 cells after Rhus tox treatment co-stimulated with lipopolysaccharide.

Conclusion: Homeopathic dilution of Rhus tox has a dual activity that increases COX-2 expression and decreases NO generation, thus modulating inflammation. Further study is needed to examine the cellular signaling mechanisms that are associated with inflammatory regulation by Rhus tox treatment in greater detail.

 
  • References

  • 1 Greenstein B.G. Adam concise clinical pharmacology. Pharmaceutical Press: London; 2007.
  • 2 Patil K.R., Patil C.R., Jadhav R.B. et al. Anti-arthritic activity of bartogenic acid isolated from fruits of Barringtonia racemosa Roxb. (Lecythidaceae). Evid Based Complement Alternat Med 2009; 2011: 27.
  • 3 Patil K.R., Patil C.R., Jadhav R.B. et al. Anti-arthritic activity of bartogenic acid isolated from fruits of Barringtonia racemosa Roxb. (Lecythidaceae). Evid Based Complement Alternat Med 2011. 2011.
  • 4 Fisher P., Scott D.L. A randomized controlled trial of homeopathy in rheumatoid arthritis. Rheumatology 2001; 40: 1052-1055.
  • 5 Vickers A., Zollman C. ABC of complementary medicine. Homoeopathy. BMJ 1999; 319: 1115-1118.
  • 6 Patil C.R., Rambhade A.D., Jadhav R.B. et al. Modulation of arthritis in rats by Toxicodendron pubescens and its homeopathic dilutions. Homeopathy 2011; 100: 131-137.
  • 7 Patil C.R., Salunkhe P.S., Gaushal M.H. et al. Immunomodulatory activity of Toxicodendron pubescens in experimental models. Homeopathy 2009; 98: 154-159.
  • 8 dos Santos A.L., Perazzo F.F., Cardoso L.G.V., Carvalho J.C.T. In vivo study of the anti-inflammatory effect of Rhus toxicodendron. Homeopathy 2007; 96: 95-101.
  • 9 Huh Y.H., Kim M.J., Yeo M.G. Homeopathic Rhus toxicodendron treatment increased the expression of cyclooxygenase-2 in primary cultured mouse chondrocytes. Homeopathy 2013; 102: 248-253.
  • 10 Hinz B., Brune K. Cyclooxygenase-2—10 years later. J Pharmacol Exp Ther 2002; 300: 367-375.
  • 11 Williams C.S., Mann M., DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999; 18: 7908-7916.
  • 12 Cheng A.W.M., Stabler T.V., Bolognesi M., Kraus V.B. Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes. Osteoarthritis Cartilage 2011; 19: 118-125.
  • 13 Abrahao A.C., Castilho R.M., Squarize C.H. et al. A role for COX2-derived PGE2 and PGE2-receptor subtypes in head and neck squamous carcinoma cell proliferation. Oral Oncol 2010; 46: 880-887.
  • 14 Martel-Pelletier J., Pelletier J.-P., Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum 2003; 33: 155-167.
  • 15 Wang P., You X., Yan Y. et al. Cyclic mechanical stretch downregulates IL-1β-induced COX-2 expression and PGE2 production in rheumatoid arthritis fibroblast-like synoviocytes. Connect Tissue Res 2011; 52: 190-197.
  • 16 Sharma J., Al-Omran A., Parvathy S. Role of nitric oxide in inflammatory diseases. Inflammopharmacology 2007; 15: 252-259.
  • 17 Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci 2004; 75: 639-653.
  • 18 Bredt D.S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 1999; 31: 577-596.
  • 19 Nagy G., Clark J.M., Buzás E.I. et al. Nitric oxide, chronic inflammation and autoimmunity. Immunol Lett 2007; 111: 1-5.
  • 20 Sun J., Zhang X., Broderick M., Fein H. Measurement of nitric oxide production in biological systems by using Griess reaction assay. Sensors 2003; 3: 276-284.
  • 21 Martich G.D., Boujoukos A.J., Suffredini A.F. Response of man to endotoxin. Immunobiology 1993; 187: 403-416.
  • 22 Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986; 89: 271-277.
  • 23 Slowing K., Carretero E., Villar A. Anti-inflammatory activity of leaf extracts of Eugenia jambos in rats. J Ethnopharmacol 1994; 43: 9-11.
  • 24 Mali S.M., Sinnathambi A., Kapase C.U. et al. Anti-arthritic activity of standardised extract of Phyllanthus amarus in Freund's complete adjuvant induced arthritis. Biomed Aging Pathol 2011; 1: 185-190.
  • 25 Alemi M., Sabouni F., Sanjarian F. et al. Anti-inflammatory effect of seeds and callus of Nigella sativa L. extracts on mix glial cells with regard to their thymoquinone content. AAPS PharmSciTech 2013; 14: 160-167.
  • 26 Patel D.R., Ansari I.A., Kachchhi Y.N. et al. Toxicodendron pubescens retains its anti-arthritic efficacy at 1M, 10M and CM homeopathic dilutions. Homeopathy 2012; 101: 165-170.
  • 27 Patil C.R., Gadekar A.R., Patel P.N. et al. Dual effect of Toxicodendron pubescens on Carrageenan induced paw edema in rats. Homeopathy 2009; 98: 88-91.
  • 28 de Oliveira C.C., Abud A.P., de Oliveira S.M. et al. Developments on drug discovery and on new therapeutics: highly diluted tinctures act as biological response modifiers. BMC Complement Altern Med 2011; 11: 101.
  • 29 Crofford L.J. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol Suppl 1997; 49: 15-19.
  • 30 Maldve R.E., Kim Y., Muga S.J., Fischer S.M. Prostaglandin E2 regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors. J Lipid Res 2000; 41: 873-881.
  • 31 Hinz B., Brune K., Pahl A. Prostaglandin E (2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochem Biophys Res Commun 2000; 272: 744.
  • 32 Cirino G., Distrutti E., Wallace J.L. Nitric oxide and inflammation. Inflamm Allergy Drug Targets 2006; 5: 115-119.